pharma · Myasthenia Gravis, Generalized
Tang-Du Hospital
Tang-Du Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include Myasthenia Gravis, Generalized. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s)
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 2
- Patents
- 0
Tocilizumab Injectable Product
Phase 2 · small molecule · Myasthenia Gravis, Generalized
Tocilizumab Injectable Product for Myasthenia Gravis, Generalized is a Phase 2 program (small_molecule) at Tang-Du Hospital with 1 ClinicalTrials.gov record(s).
Internal code V4.0, 20220410
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Tang-Du Hospital
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Myasthenia Gravis, Generalized
- Status
- active
- Trials
- 1